山东大学耳鼻喉眼学报 ›› 2023, Vol. 37 ›› Issue (5): 42-49.doi: 10.6040/j.issn.1673-3770.0.2022.471

• 论著 • 上一篇    下一篇

翼管神经切断术治疗2型慢性鼻窦炎伴过敏性鼻炎的临床疗效分析

王晓嫒,张欠欠,程翔宇,李志鹏,张维天,叶海波   

  1. 上海交通大学医学院附属第六人民医院 耳鼻咽喉头颈外科/上海交通大学耳鼻咽喉头颈外科研究所/上海市睡眠呼吸障碍疾病重点实验室, 上海 200233
  • 发布日期:2023-10-13
  • 通讯作者: 叶海波. E-mail:yehaibo_2012@163.com
  • 基金资助:
    国家自然科学基金项目(82000951,82071014,82271137,81870700)

A clinical efficacy analysis of vidian neurectomy in the treatment of type 2 chronic rhinosinusitis with allergic rhinitis

WANG Xiaoai, ZHANG Qianqian, CHENG Xiangyu, LI Zhipeng, ZHANG Weitian, YE Haibo   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine/Otolaryngology Institute of Shanghai Jiao Tong University/Shanghai Key Laboratory of Sleep Disordered Breathing, Shanghai 200233, China
  • Published:2023-10-13

PDF (PC)

91

摘要： 目的 探讨翼管神经切断术(vidian neurectomy, VN)治疗2型慢性鼻窦炎伴过敏性鼻炎(chronic rhinosinusitis with allergic rhinitis, CRSwAR)的临床疗效及价值。 方法 回顾性研究接受内镜鼻窦手术(endoscopic sinus surgery, ESS)联合VN治疗的47例中重度2型CRSwAR患者,通过鼻腔鼻窦结局测试-22条(sinonasal outcome test-22, SNOT-22)问卷、过敏相关血清学检查(外周血嗜酸性粒细胞、血清总免疫球蛋白E、血清过敏原等)、电子鼻咽镜(Lund-Kennedy评分法)和鼻窦CT(Lund-Mackay评分法)评估患者术前及术后1年的病情严重程度及病变范围。 结果 患者术前SNOT-22评分为［38.00(23.00, 54.25)］分,术后1年评分为［10.00(5.00,18.50)］分,较术前降低,差异有统计学意义(P<0.001)。其中鼻塞、打喷嚏、流清涕、流脓涕、嗅觉减退的临床症状均有改善且评分低于治疗前,差异有统计学意义(P<0.001)。术前Lund-Kennedy评分、Lund-Mackay评分分别为［9.00(6.75,12.00)］分、［15.50(10.75,22.00)］分,术后1年评分分别为［3.00(2.00,4.00)］、［3.50(1.00,6.50)］分,差异均有统计学意义(P<0.001)。术后1个月出现眼干者有18例(38.30%),出现上腭麻木者有2例(4.26%),随访1年除2例患者仍有眼干外,余患者眼干、上腭麻木症状基本消失,无颅、眼眶等严重并发症发生。2型CRSwAR患者术后1年治疗总有效率为89.36%。外周血嗜酸性粒细胞、血清总免疫球蛋白E、血清过敏原等指标治疗前后改变差异无统计学意义(P=0.130,P=0.184,P=0.763)。 结论 ESS联合VN是治疗中重度2型CRSwAR的安全、有效的手段,能明显改善鼻塞、流涕、打喷嚏、嗅觉减退等症状,且无严重并发症发生。

关键词: 翼管神经切断术, 内镜鼻窦手术, 2型慢性鼻窦炎, 过敏性鼻炎, 临床疗效

Abstract: Objective To investigate the clinical efficacy and vidian neurectomy(VN)in the treatment of type 2 chronic rhinosinusitis with allergic rhinitis(CRSwAR). Methods This was a retrospective study of 47 patients with moderate to severe type 2 CRSwAR who presented to our department for endoscopic sinus surgery(ESS)combined with VN surgery, from September 2019 to September 2021. The severity and extent of the patient's disease preoperatively and 1 year postoperatively were assessed using the sinonasal outcome test-22(SNOT-22)questionnaire, allergy-related serology(peripheral blood eosinophils, serum total immunoglobulin E, serum allergens, etc.), electronic nasopharyngoscopy(Lund-Kennedy scale), and the sinus CT(Lund-Mackay scale). Results From the analysis, the preoperative and 1-year postoperative SNOT-22 score was ［38.00(23.00,54.25)］ and ［10.00(5.00,18.50)］, respectively. The postoperative score was significantly lower than the preoperative score, and the difference before and after treatment was statistically significant(P<0.001). The clinical symptoms of nasal obstruction, sneezing, clear runny nose, rhinorrhea and reduction of smell all improved after treatment as indicated by the significantly lower scores after treatment than before treatment(P<0.001). The preoperative Lund-Kennedy and Lund-Mackay scores were ［9.00(6.75,12.00)］ and ［15.50(10.75,22.00)］ respectively, while 1 year postoperatively, these scores were significantly different at ［3.00(2.00,4.00)］ and ［3.50(1.00,6.50)］ respectively(P<0.001). One month after surgery, 18 patients(38.30%)had dry eyes and 2 patients(4.26%)had numbness in the palate. At 1 year follow-up, except for 2 patients who still had dry eyes, the symptoms of dry eyes and numbness in the palate basically disappeared and no serious complications such as cranial or orbital problems occurred. The total effective rate of treatment at 1 year after surgery was 89.36% for patients with type 2 CRSwAR. The changes in peripheral blood eosinophils, total serum immunoglobulin E and serum allergens before and after treatment were not statistically significant(P=0.130,P=0.184,P=0.763). Conclusion ESS combined with VN is a safe and effective treatment for moderate to severe type 2 CRSwAR, significantly improving symptoms of nasal obstruction, rhinorrhea, sneezing and reduction of smell without serious complications.

Key words: Vidian neurectomy, Endoscopic sinus surgery, Type 2 chronic rhinosinusitis, Allergic rhinitis, Clinical efficacy

中图分类号: 

  • R765.21
[1] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl S29): 1-464. doi:10.4193/Rhin20.600
[2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi: 10.3760/cma.j.issn.1673-0860.2019.02.001
[3] Liao B, Liu JX, Li ZY, et al. Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes[J]. Allergy, 2018, 73(7): 1459-1469. doi:10.1111/all.13411
[4] Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the pediatric allergies in america survey[J]. J Allergy Clin Immunol, 2009, 124(3 Suppl): S43-S70. doi:10.1016/j.jaci.2009.05.013
[5] 李添应, 陈德华, 林志斌, 等. 舌下含服粉尘螨滴剂治疗变应性鼻炎的疗效观察[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(10): 859-862. doi:10.3760/cma.j.issn.1673-0860.2011.10.014 LI Tianying, CHEN Dehua, LIN Zhibin, et al. Efficacy of sublingual immunotherapy with dermatophagoides farianae drops in patients with allergic rhinitis[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2011, 46(10): 859-862. doi:10.3760/cma.j.issn.1673-0860.2011.10.014
[6] 娄鸿飞, 黄嫣然, 王成硕, 等. 尘螨特异性皮下免疫治疗在变应性鼻炎患者中的远期疗效研究[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(21): 1627-1631. doi:10.13201/j.issn.1001-1781.2018.21.006 LOU Hongfei, HUANG Yanran, WANG Chengshuo, et al. Long-term efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2018, 32(21): 1627-1631. doi:10.13201/j.issn.1001-1781.2018.21.006
[7] Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma(ARIA)guidelines-2016 revision[J]. J Allergy Clin Immunol, 2017, 140(4): 950-958. doi:10.1016/j.jaci.2017.03.050
[8] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南(2022年,修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 106-129. doi: 10.3760/cma.j.cn115330-20211228-00828
[9] 中华医学会耳鼻咽喉科学分会, 中华耳鼻咽喉科杂志编辑委员会. 附:慢性鼻窦炎鼻息肉临床分型分期及内窥镜鼻窦手术疗效评定标准(1997年,海口)[J].中华耳鼻咽喉科杂志, 1998(3): 6
[10] 敖天, 程雷. 慢性鼻窦炎伴鼻息肉的内型研究及其指导下的精准控制与治疗[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 7-14. doi:10.6040/j.issn.1673-3770.1.2022.005 AO Tian, CHENG Lei. An endotype study of chronic rhinosinusitis with nasal polyps and precise control and treatment under the guidance[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 7-14. doi:10.6040/j.issn.1673-3770.1.2022.005
[11] Grayson JW, Hopkins C, Mori, et al. Contemporary classification of chronic rhinosinusitis beyond polyps vs No polyps: a review[J]. JAMA Otolaryngol Head Neck Surg, 2020, 146(9): 831-838. doi:10.1001/jamaoto.2020.1453
[12] Lou HF, Meng YF, Piao YS, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2016, 54(2): 150-159. doi:10.4193/Rhino15.271
[13] Wen WP, Liu WL, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy[J]. J Allergy Clin Immunol, 2012, 129(6): 1522-1528.e5. doi:10.1016/j.jaci.2012.01.079
[14] Cao PP, Wang ZC, Schleimer RP, et al. Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes[J]. Ann Allergy Asthma Immunol, 2019, 122(1): 33-40. doi:10.1016/j.anai.2018.10.014
[15] 张秩荻, 马芙蓉, 刘俊秀, 等. 鼻分泌物Ⅱ型炎症细胞因子在嗜酸粒细胞型慢性鼻窦炎伴鼻息肉中的表达及其预测价值[J].临床耳鼻咽喉头颈外科杂志, 2022, 36(12): 934939. doi: 10.13201/j.issn.2096-7993.2022.12.009
[16] 王鸿, 张罗, 周兵, 等. 慢性鼻窦炎鼻息肉与变应性因素相关性的探讨[J]. 中华耳鼻咽喉头颈外科杂志, 2005, 40(3): 168-171. doi:10.3760/j.issn: 1673-0860.2005.03.004 WANG Hong, ZHANG Luo, ZHOU Bing, et al. Relationship between allergic factors and chronic sinusitis with or without nasal polyps[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2005, 40(3): 168-171. doi:10.3760/j.issn: 1673-0860.2005.03.004
[17] De Greve G, Hellings PW, Fokkens WJ, et al. Endotype-driven treatment in chronic upper airway diseases[J]. Clin Transl Allergy, 2017, 7: 22. doi:10.1186/s13601-017-0157-8
[18] Baroody FM. Allergic rhinitis: broader disease effects and implications for management[J]. Otolaryngol Head Neck Surg, 2003, 128(5): 616-631. doi:10.1016/S0194-59980300257-2
[19] Li S, Cheng JZ, Yang JP, et al. Efficacy of posterior nasal neurectomy for allergic rhinitis combined with chronic rhinosinusitis with nasal polyps[J]. Acta Otolaryngol, 2019, 139(10): 890-894. doi:10.1080/00016489.2019.1654132
[20] Qi Y, Liu JQ, Peng SY, et al. Efficacy of selective vidian neurectomy for allergic rhinitis combined with chronic rhinosinusitis[J]. ORL J Otorhinolaryngol Relat Spec, 2021, 83(5): 327-334. doi:10.1159/000512083
[21] 齐岩, 刘俊其, 彭舒娅, 等. 鼻内镜下选择性翼管神经切断术对伴有变应性鼻炎的慢性鼻窦炎的疗效观察[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 109-113. doi:10.6040/j.issn.1673-3770.1.2018.028 QI Yan, LIU Junqi, PENG Shuya, et al. Therapeutic ecacy of endoscopic elective vidian neurectomy for moderate-severe persistent allergic rhinitis with chronic sinusitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(1): 109-113. doi:10.6040/j.issn.1673-3770.1.2018.028
[22] GOLDING-WOOD PH. Observations on petrosal and vidian neurectomy in chronic vasomotor rhinitis[J]. J Laryngol Otol, 1961, 75: 232-247. doi:10.1017/s0022215100057716
[23] van Gerven L, Boeckxstaens G, Hellings P. Up-date on neuro-immune mechanisms involved in allergic and non-allergic rhinitis[J]. Rhinology, 2012, 50(3): 227-235. doi:10.4193/Rhino.11.152
[24] Pavlov VA, Chavan SS, Tracey KJ. Molecular and functional neuroscience in immunity[J]. Annu Rev Immunol, 2018, 36: 783-812. doi:10.1146/annurev-immunol-042617-053158
[25] Kamimura D, Tanaka Y, Hasebe R, et al. Bidirectional communication between neural and immune systems[J]. Int Immunol, 2020, 32(11): 693-701. doi:10.1093/intimm/dxz083
[26] Konno A. Historical, pathophysiological, and therapeutic aspects of vidian neurectomy[J]. Curr Allergy Asthma Rep, 2010, 10(2): 105-112. doi:10.1007/s11882-010-0093-3
[27] 余少卿, 王向东, 徐睿, 等. 变应性鼻炎的外科手术治疗专家共识(2022, 上海)[J]. 中国耳鼻咽喉颅底外科杂志, 2022, 28(1): 7-17. doi:10.11798/j.issn.1007-1520.202201001 YU Shaoqing, WANG Xiangdong, XU Rui, et al. Expert consensus on surgical management of allergic rhinitis(2022, Shanghai)[J]. Chinese Journal of Otorhinolaryngology-skull Base Surgery, 2022, 28(1): 7-17. doi:10.11798/j.issn.1007-1520.202201001
[28] 李松, 王宗贵, 杨景朴, 等. 鼻内镜下翼管神经切断术进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 72-76. doi:10.6040/j.issn.1673-3770.0.2017.312 LI Song, WANG Zonggui, YANG Jingpu, et al. Progress of transnasal endoscopic vidian neurectomy[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(1): 72-76. doi:10.6040/j.issn.1673-3770.0.2017.312
[29] 蔡智谋, 于超生, 文忠. 鼻内镜下鼻后神经切断术研究进展[J]. 中国耳鼻咽喉颅底外科杂志, 2020, 26(1): 105-108. doi:10.11798/j.issn.1007-1520.202001026 CAI Zhimou, YU Chaosheng, WEN Zhong. The research progress on the endoscopic posterior neurectomy[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2020, 26(1): 105-108. doi:10.11798/j.issn.1007-1520.202001026
[30] 张彬, 徐明, 王卢莎, 等. 经鼻内镜鼻后神经切断治疗嗜酸性粒细胞型慢性鼻窦炎的短期疗效观察[J]. 中国耳鼻咽喉头颈外科, 2022, 29(1): 45-47. doi:10.16066/j.1672-7002.2022.01.011 ZHANG Bin, XU Ming, WANG Lusha, et al. Efficacy of endoscopic posterior nasal neurectomy treating eosinophilic chronic rhinosinusitis[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2022, 29(1): 45-47. doi:10.16066/j.1672-7002.2022.01.011
[31] 李晓光, 陈建伟, 姜霞, 等. 高选择性鼻后神经丛切断术治疗中重度常年性变应性鼻炎近期疗效观察[J]. 中国耳鼻咽喉颅底外科杂志, 2022, 28(1): 18-21. doi:10.11798/j.issn.1007-1520.202221352 LI Xiaoguang, CHEN Jianwei, JIANG Xia, et al. Observation of short-term treatment effect of highly selective posterior nasal neurectomy on patients with moderate-severe perennial allergic rhinitis[J]. Chinese Journal of Otorhinolaryngology-skull Base Surgery, 2022, 28(1): 18-21. doi:10.11798/j.issn.1007-1520.202221352
[32] Dalziel K, Stein K, Round A, et al. Endoscopic sinus surgery for the excision of nasal polyps: a systematic review of safety and effectiveness[J]. Am J Rhinol, 2006, 20(5): 506-519. doi:10.2500/ajr.2006.20.2923
[33] Bachert C. Innovative therapeutic targets in chronic sinusitis with nasal polyps[J]. Braz J Otorhinolaryngol, 2016, 82(3): 251-252. doi:10.1016/j.bjorl.2016.03.001
[34] 李华斌, 冯韶燕, 程岚. 嗜酸粒细胞性慢性鼻窦炎的临床特点和治疗策略 [J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(3): 177-179. doi: 10.13201/j.issn.1001-1781.2016.03.001
[35] 王宠舒, 郭翠莲, 刘争. 内在型对慢性鼻窦炎患者临床结局的影响 [J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(5): 644-648. doi: 10.3760/cma.j.cn115330-20210509-00262
[36] 娄鸿飞, 王成硕. 慢性鼻窦炎分型研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 10-13. doi:10.6040/j.issn.1673-3770.1.2018.008
[37] Nishijima H, Kondo K, Toma-Hirano M, et al. Denervation of nasal mucosa induced by posterior nasal neurectomy suppresses nasal secretion, not hypersensitivity, in an allergic rhinitis rat model[J]. Lab Investig, 2016, 96(9): 981-993. doi:10.1038/labinvest.2016.72LOU Hongfei, WANG Chengshuo. Progress in classification of chronic sinusitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(3): 10-13. doi:10.6040/j.issn.1673-3770.1.2018.008
[38] Nishijima H, Kondo K, Toma-Hirano M, et al. Prolonged denervation induces remodeling of nasal mucosa in rat model of posterior nasal neurectomy[J]. Int Forum Allergy Rhinol, 2017, 7(7): 670-678. doi:10.1002/alr.21952
[39] Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN[J]. Allergy, 2007, 62(Suppl 84): 1-41. doi:10.1111/j.1398-9995.2007.01551.x
[40] Wheatley LM, Togias A. Clinical practice. allergic rhinitis[J]. N Engl J Med, 2015, 372(5): 456-463. doi:10.1056/NEJMcp1412282
[41] Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study[J]. Pediatrics, 1968, 42(5): 793-802.
[42] Virchow JC, Backer V, Kuna P, et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial[J]. JAMA, 2016, 315(16): 1715-1725. doi:10.1001/jama.2016.3964
[43] Feng ML, Zeng XH, Li J. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis[J]. J Thorac Dis, 2019, 11(8): 3616-3625. doi:10.21037/jtd.2019.06.35
[44] 艾金刚, 卿翔, 郜儒, 等. 内镜下翼管神经切断术治疗变应性鼻炎合并支气管哮喘的疗效评估[J]. 中华耳鼻咽喉头颈外科杂志, 2020, 55(5): 452-457. doi: 10.3760/cma.j.cn115330-20200429-00349 AI Jingang, QING Xiang, GAO Ru, et al. Effect of endoscopic vidian neurectomy in patients with coexisting allergic rhinitis and bronchial asthma[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2020, 55(5): 452-457. doi: 10.3760/cma.j.cn115330-20200429-00349
[45] Ai JG, Xie ZZ, Qing X, et al. Clinical effect of endoscopic vidian neurectomy on bronchial asthma outcomes in patients with coexisting refractory allergic rhinitis and asthma[J]. Am J Rhinol Allergy, 2018, 32(3): 139-146. doi:10.1177/1945892418764964
[1] 王剑,杜伟嘉,薛涛,陈福权. 利用百度指数分析中国过敏性鼻炎及相关变应性疾病的流行特征[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 31-41.
[2] 毕晓云,马本绪,王心茹,李旭豪,杨继国. 穴位贴敷治疗小儿过敏性鼻炎随机对照试验的Meta分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 75-85.
[3] 王惟一,时蕾,张志玉,张贵玲,时光刚. 高脂饮食对过敏性鼻炎小鼠致敏影响和肠道菌群改变的研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 21-29.
[4] 王欢,胡俐,余洪猛. 慢性鼻窦炎相关嗅觉功能障碍研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 43-49.
[5] 曹轩,肖旭平,李云秋. 透明质酸在慢性鼻窦炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 104-109.
[6] 张雅琪,刘慧敏,曹淋曼,王子钰,林旭,李燕萍,薛刚,吴靖芳. MAPK、PI3K-AKT、NF-κB在小鼠过敏性鼻炎中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 254-259.
[7] 庞冲,边赛男,张冰,尹旭,陆颖霞,叶鹏飞,王湛,赵晶,高彦,关凯. 儿童过敏性鼻炎粉尘螨特异性舌下免疫治疗短期疗效评估[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 70-74.
[8] 秦贺,万宝刚,王洪丽,赵本绮. CT检查在真菌球型鼻窦炎术前诊断中的临床意义[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 32-35.
[9] 王鑫,刘巧平,闫占峰,刘思溟,朱雅静,丁倩,张莹,田媛,张京然. 基于网络药理学探究小青龙汤治疗过敏性鼻炎的作用机制[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 46-55.
[10] 王宇婷，王嘉玺. microRNA在过敏性鼻炎发病机制中的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 98-104.
[11] 李化静,郝润梅,戴皓,张令,申震,权芳,邵渊. 儿茶素抑制卵清蛋白诱导的过敏性鼻炎小鼠模型炎症反应的机制研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 1-7.
[12] 林育珊,卢标清. 从心脾论治突发性耳聋的疗效观察[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 6-11.
[13] 林兴,沈翎,林宗通,杨中婕. 儿童鼻腔异物与过敏性鼻炎关系的初步研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 101-104.
[14] 徐海侠,崔晓波,刘佳荣,李欣,刘佳宜,刘晓玲. 内蒙古呼和浩特城区气传致敏花粉流行情况调查[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 106-109.
[15] 张俊军,刘海莉,刘加福,秦小奉,杜洪明,王厚慧. 糖皮质激素不同给药方式治疗突发性聋的临床疗效及安全性研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 52-55.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发